stockrow
Saturday 7 November 2026
Export ZURA’s income statement to Excel — free account
Zura Bio Limited
ZURA Healthcare Biotechnology
- EPS
- +3.71%
- Free cash flow
- −26.2%
Quarter to September 2026, against a year earlier
4.11
0.39
+10.48%
Follow ZURA
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
| (85.05%) | (71.76%) | (59.52%) | (79.52%) |
+8 more TTM periods Free account |
|
| (72.21%) | (62.74%) | (52.92%) | (67.71%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(69.94%) | (59.92%) | (49.28%) | (99.33%) | |
Average Days of Receivables |
— | — | — | — | |
Free Cash Flow per Share |
(0.64) | (0.61) | (0.65) | (0.69) | |
Free Cash Flow |
(81.69) | (77.63) | (72.75) | (64.93) | |
Capital Expenditures |
(0.09) | (0.09) | (0.08) | (0.11) | |
| Other line items | |||||
Cash ROIC |
(22.36%) | (19.30%) | (16.44%) | (30.78%) | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Operating CF/Net income |
0.67 | 0.67 | 0.68 | 0.65 | |
Depreciation/Fixed assets |
0.44 | 0.41 | 0.45 | 0.39 | |
Capex/Depreciation |
(1.34) | (1.41) | (1.37) | (2.31) | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.64) | (0.61) | (0.65) | (0.69) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates · fundamentals updated 2 Nov 2026